POTS (postural orthostatic tachycardia syndrome) does not directly cause atrial fibrillation, but the autonomic imbalance that drives POTS can create conditions that make irregular heart rhythms more likely over time. The fast heart rate in POTS is sinus tachycardia, a normal rhythm that’s simply too fast, which is fundamentally different from the chaotic electrical signals of afib. Still, the overlap between these two conditions is real, and the connection deserves a closer look.
Why POTS and Afib Are Different Problems
POTS produces sinus tachycardia, meaning the heart’s natural pacemaker is firing correctly but at an elevated rate, typically 30 or more beats per minute above baseline when you stand up. The rhythm is regular and predictable. Atrial fibrillation, by contrast, involves disorganized electrical activity in the upper chambers of the heart, producing an irregular and often rapid heartbeat.
Clinicians distinguish between the two partly by how the fast heart rate behaves. In POTS, the heart rate rises gradually with position changes and is tied to standing or exertion. Afib tends to have a more sudden onset and offset, and the rhythm itself is irregular rather than steady. If tachycardia stops when you perform a Valsalva maneuver (bearing down as if straining), that also points away from POTS and toward a different type of arrhythmia. An EKG can confirm the difference definitively.
How Autonomic Imbalance Connects the Two
The nervous system imbalance at the core of POTS could, in theory, set the stage for arrhythmias like afib. People with POTS have elevated sympathetic nervous system activity (the “fight or flight” side) and reduced parasympathetic tone (the “rest and digest” side). This imbalance increases stimulation of receptors on heart cells that speed up electrical firing and calcium flow, keeping the heart in a state of heightened excitability.
Research published in the Journal of the American Heart Association confirmed that POTS patients show significantly reduced markers of parasympathetic heart control compared to healthy individuals. This shift toward chronic sympathetic overdrive doesn’t just raise heart rate. It changes how the heart’s electrical system behaves at a cellular level, which is the kind of environment where abnormal rhythms can theoretically emerge.
Cardiac Remodeling in POTS
A study in JACC: Clinical Electrophysiology found something surprising: POTS patients show measurable changes in the heart’s electrical and structural properties, even though the heart has traditionally been considered normal in this condition. Compared to controls, POTS patients had smaller left atrial volumes, higher resting heart rates (averaging 78 beats per minute versus 70), and significant delays in electrical conduction through both the atria and ventricles.
These conduction delays are notable because slowed or uneven electrical signaling through the atria is one of the recognized precursors to atrial fibrillation in the general population. The researchers noted they couldn’t determine whether these changes were a cause or a consequence of POTS, but the finding establishes that the heart in POTS is not electrically “normal” in the way previously assumed. Whether this remodeling progresses enough over years to trigger afib in some patients remains an open question, but the structural groundwork is there.
What the Numbers Actually Show
Hard data on how often POTS patients develop afib is limited. One large study examining patients with Marfan syndrome found that among those who also had POTS, 4.6% had atrial fibrillation. Importantly, 95.1% of the Marfan patients with POTS had no history of arrhythmia at all. This is a very specific population (Marfan syndrome involves connective tissue abnormalities that independently affect the heart), so the numbers don’t translate directly to all POTS patients.
The typical POTS patient is a young woman. The condition predominantly affects females (94% of cases) with a 5:1 female-to-male ratio, and the average age of symptom onset is around 21 years, with the most common onset age being 14. Atrial fibrillation, on the other hand, is primarily a condition of aging. It’s uncommon in people under 50 and rises sharply with each decade of life. This demographic mismatch means that most POTS patients are simply too young and otherwise too healthy to develop afib, regardless of any autonomic imbalance.
Overlapping Conditions That Raise Risk
Some conditions that travel alongside POTS may independently increase arrhythmia risk. Hypermobile Ehlers-Danlos syndrome (hEDS), a connective tissue disorder, overlaps heavily with POTS. An estimated two-thirds of people with hEDS experience problems with blood pressure and heart rate regulation when upright, and roughly 41 to 49% of those meet criteria for POTS. The generalized tissue laxity in hEDS makes blood vessels overly stretchy, which worsens blood pooling and triggers compensatory heart rate increases.
People with EDS also have higher rates of small fiber neuropathy, a type of nerve damage that can worsen autonomic dysfunction. When you layer connective tissue problems, nerve damage, and autonomic imbalance together, the cumulative stress on the cardiovascular system is greater than POTS alone. For patients with these overlapping conditions, closer cardiac monitoring makes sense.
How POTS Treatments Affect Heart Rhythm
Several common POTS treatments work by calming the heart rate or correcting the autonomic imbalance, which could theoretically reduce any arrhythmia-promoting conditions rather than worsen them.
- Beta-blockers lower heart rate by dampening sympathetic nerve activity and reducing stress hormone levels. They are also one of the standard treatments for controlling heart rate in atrial fibrillation, so they serve double duty if both conditions are present.
- Ivabradine slows the heart by targeting the specific electrical current in the heart’s natural pacemaker. It lowers heart rate without dropping blood pressure, which matters for POTS patients who often already run low.
- Pyridostigmine boosts parasympathetic tone by increasing the availability of a key signaling molecule at nerve endings. This directly counteracts the sympathetic overdrive in POTS, nudging the autonomic balance back toward normal.
Midodrine, which tightens blood vessels to improve blood return to the heart, does not directly affect heart rhythm. However, it can cause high blood pressure when lying down, so evening doses are typically avoided. Fludrocortisone expands blood volume and can lower potassium levels over time, which is worth watching since low potassium is itself a trigger for heart rhythm problems.
Telling the Difference When Your Heart Races
If you have POTS and notice episodes where your heart feels like it’s racing erratically rather than just fast, pay attention to the pattern. POTS-related tachycardia is positional: it worsens when you stand and improves when you sit or lie down. The heart rate climbs gradually rather than snapping to a high rate instantly. Your pulse, if you check it, will feel fast but regular.
Afib feels different. The rhythm is uneven, sometimes described as a fluttering or quivering sensation. It can start and stop abruptly regardless of position. You might also notice unusual fatigue, dizziness beyond what’s typical for your POTS, or shortness of breath that doesn’t match your usual symptoms. A portable heart monitor or smartwatch with an EKG feature can capture what’s happening during an episode, which gives your doctor something concrete to evaluate. If your symptoms have changed in character, not just severity, that’s worth investigating rather than assuming it’s just a bad POTS day.